Prematurity and neonatal screening;Prématurité et dépistage néonatal

Archives de Pediatrie

Volumn 15, Issue SUPPL. 1, 2008, Pages

  Dhondt, J L ^a  

^a Centre Hospitalier Saint Philibert GHICL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PHENYLALANINE; PROGESTERONE; STEROID 21 MONOOXYGENASE; THYROTROPIN; TRYPSIN;

ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONGENITAL HYPOTHYROIDISM; DEMOGRAPHY; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; GESTATIONAL AGE; HEALTH PROGRAM; HUMAN; IMMUNOREACTIVITY; INTENSIVE CARE; MEASUREMENT ERROR; NEWBORN CARE; NEWBORN SCREENING; PHENYLKETONURIA; PREMATURITY; REPEAT PROCEDURE; SCREENING TEST;

FRANCE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; NEONATAL SCREENING;

EID: 52149110827     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(08)73941-1     Document Type: Article

References (18)

1. Bickel H., Gerrard J., and Hickmans E.M. Influence of phenylalanine intake on phenylketonuria. Lancet 2 (1953) 812-813
2. Guthrie R., and Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32 (1963) 338
3. Dhondt J.L., Farriaux J.P., Briard M.L., et al. Neonatal screening in France. Screening 2 (1993) 77-85
4. Farriaux J.P., Vidailhet M., Briard M.L., et al. Neonatal screening for cystic fibrosis: France rises to the challenge. J Inherit Metal Dis 26 (2003) 729-744
5. Lucas A., Baker B.A., and Morley R.M. Hyperphenylalaninaemia and outcome in intravenously fed preterm neonates. Arch Dis Child 68 (1993) 579-583
6. Larson C., Hermos R., Delaney A., et al. Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism. J Pediatr 143 (2003) 587-591
7. Beeram M.R., and Wilson D.P. Hypothyroxinemia of prematurity: rite of passage or therapeutic necessity?. Tex Med 96 (2000) 60-63
8. McElduff A., McElduff P., Wiley V., et al. Neonatal thyrotropin as measured in a congenital hypothyroidism screening program: influence of the mode of delivery. J Clin Endocrinol Metab 90 (2005) 6361-6363
9. Weber G., Vigone M.C., Rapa A., et al. Neonatal transient hypothyroidism: aetiological study. Italian Collaborative Study on Transient Hypothyroidism. Arch Dis Child Fetal Neonatal Ed 79 (1998) F70-F72
10. van der Kamp H.J., Oudshoorn C.G., Elvers B.H., et al. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. J Clin Endocrinol Metab 90 (2005) 3904-3907
11. Minutti C.Z., Lacey J.M., Magera M.J., et al. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 89 (2004) 3687-3693
12. Kosel S., Burggraf S., Fingerhut R., et al. Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency. Clin Chem 51 (2005) 298-304
13. Working group on neonatal screening of the European society for paediatric endocrinology. Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 55 (2001) 201-205
14. Honour J.W., and Torresani T. Evaluation of Neonatal Screening for congenital adrenal hyperplasia. Horm Res 55 (2001) 206-211
15. Farriaux J.P., Vidailhet M., Briard M.L., et al. Neonatal screening for cystic fibrosis: France rises to the challenge. J Inherit Metal Dis 26 (2003) 729-744
16. Munck A, Dhondt JL, Sahler C, Roussey M. Implementation of the French nationwide cystic fibrosis newborn screening program: organization, optimization and outcomes over two million tests. (soumis à publication)
17. Gray J.E., Sorrentino J.E., Matheson G.A., et al. Failure to screen newborns for inborn disorders: a potential consequence of changes in newborn care. Early Hum Dev 48 (1997) 279-285
18. Tylek-Lemanska D., Kumorowicz-Kopiec M., and Starzyk J. Screening for congenital hypothyroidism: the value of retesting after four weeks in neonates with low and very low birth weight. J Med Screen 12 (2005) 166-169